Connor, Clark & Lunn Investment Management Ltd. Amneal Pharmaceuticals, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 548,975 shares of AMRX stock, worth $4.43 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
548,975
Previous 558,113
1.64%
Holding current value
$4.43 Million
Previous $3.54 Million
28.87%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding AMRX
# of Institutions
185Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$176 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$118 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$99.5 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$91 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$86.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.22B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...